246 related articles for article (PubMed ID: 34636915)
1. Preferences for More or Less Health Care and Association With Health Literacy of Men Eligible for Prostate-Specific Antigen Screening in Australia.
Pickles K; Scherer LD; Cvejic E; Hersch J; Barratt A; McCaffery KJ
JAMA Netw Open; 2021 Oct; 4(10):e2128380. PubMed ID: 34636915
[TBL] [Abstract][Full Text] [Related]
2. Medical Maximizing-Minimizing Preferences Predict Responses to Information about Prostate-Specific Antigen Screening.
Scherer LD; Kullgren JT; Caverly T; Scherer AM; Shaffer VA; Fagerlin A; Zikmund-Fisher BJ
Med Decis Making; 2018 Aug; 38(6):708-718. PubMed ID: 29916784
[TBL] [Abstract][Full Text] [Related]
3. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated with Informed Decisions and Participation in Bowel Cancer Screening among Adults with Lower Education and Literacy.
Smith SK; Simpson JM; Trevena LJ; McCaffery KJ
Med Decis Making; 2014 Aug; 34(6):756-72. PubMed ID: 24421292
[TBL] [Abstract][Full Text] [Related]
5. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
6. Comparing 3 techniques for eliciting patient values for decision making about prostate-specific antigen screening: a randomized controlled trial.
Pignone MP; Howard K; Brenner AT; Crutchfield TM; Hawley ST; Lewis CL; Sheridan SL
JAMA Intern Med; 2013 Mar; 173(5):362-8. PubMed ID: 23400279
[TBL] [Abstract][Full Text] [Related]
7. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.
Nguyen DD; Trinh QD; Cole AP; Kilbridge KL; Mahal BA; Hayn M; Hansen M; Han PKJ; Sammon JD
Cancer; 2021 Jan; 127(2):249-256. PubMed ID: 33165954
[TBL] [Abstract][Full Text] [Related]
8. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
[TBL] [Abstract][Full Text] [Related]
9. A comparison of US and Australian men's values and preferences for PSA screening.
Howard K; Brenner AT; Lewis C; Sheridan S; Crutchfield T; Hawley S; Nielsen ME; Pignone MP
BMC Health Serv Res; 2013 Oct; 13():388. PubMed ID: 24093428
[TBL] [Abstract][Full Text] [Related]
10. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
Gattellari M; Ward JE
J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
[TBL] [Abstract][Full Text] [Related]
12. Evaluating two decision aids for Australian men supporting informed decisions about prostate cancer screening: A randomised controlled trial.
Pickles K; Kazda L; Barratt A; McGeechan K; Hersch J; McCaffery K
PLoS One; 2020; 15(1):e0227304. PubMed ID: 31940376
[TBL] [Abstract][Full Text] [Related]
13. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
[TBL] [Abstract][Full Text] [Related]
14. Exploring patient perceptions of PSA screening for prostate cancer: risks, effectiveness, and importance.
Smith SD; Birtwhistle R
Can Fam Physician; 2012 Sep; 58(9):e502-7. PubMed ID: 22972741
[TBL] [Abstract][Full Text] [Related]
15. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
[TBL] [Abstract][Full Text] [Related]
16. A patient recall program to enhance decisions about prostate cancer screening: a feasibility study.
Denberg TD; Bhide M; Soenksen A; Mizrahi T; Shields L; Lin CT
BMC Fam Pract; 2009 Nov; 10():75. PubMed ID: 19948028
[TBL] [Abstract][Full Text] [Related]
17. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
[TBL] [Abstract][Full Text] [Related]
18. Decision aids for people facing health treatment or screening decisions.
Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
[TBL] [Abstract][Full Text] [Related]
19. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
Pickles K; Carter SM; Rychetnik L
BMJ Open; 2015 Mar; 5(3):e006367. PubMed ID: 25783420
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
